These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7129911)

  • 41. [A comparative study of DNA measurement of bladder cancer from image cytometry and chromosome aberration in in situ hybridization].
    Nemoto R; Nakamura I; Uchida K; Harada M
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():153-7. PubMed ID: 7611780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Staging and prognosis of T3b bladder cancer.
    Levy DA; Grossman HB
    Semin Urol Oncol; 1996 May; 14(2):56-61. PubMed ID: 8734732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of bladder cancer by analysis of urinary fibronectin.
    Menéndez V; Fernández-Suárez A; Galán JA; Pérez M; García-López F
    Urology; 2005 Feb; 65(2):284-9. PubMed ID: 15708039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the prognosis for cancer of the bladder].
    Cooper EH; Anderson CK
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):814-5. PubMed ID: 4452963
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
    Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
    Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extrapulmonary small cell carcinoma of the bladder.
    Shahab N
    Semin Oncol; 2007 Feb; 34(1):15-21. PubMed ID: 17270661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
    Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
    BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.
    Schultz IJ; Witjes JA; Swinkels DW; de Kok JB
    Clin Chim Acta; 2006 Jun; 368(1-2):20-32. PubMed ID: 16480698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of detection of specific nuclear protein of matrix 22 in the urine in diagnosis of urinary bladder cancer].
    Darenkov SP; Perlin DV; Chernyshev IV; Parshina VN; Ivanov AV; Iarovoĭ SK
    Urologiia; 2006; (6):48, 49-51. PubMed ID: 17315713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The prognostic factors in bladder cancer patients].
    al-Shukri SKh; Korneev IA
    Urol Nefrol (Mosk); 1996; (6):49-53. PubMed ID: 9036614
    [No Abstract]   [Full Text] [Related]  

  • 53. [Early diagnosis of bladder cancer by special fluorescence spectrum: an in vitro experiment].
    Zou J; He HC; Yao YB; Dai QS; Han ZD; Zhong WD
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2544-6. PubMed ID: 18067829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique).
    Fernandez-Gomez J; Escaf Barmadah S; Gosalbez D; Rodriguez-Faba O; Jalon A; Gonzalez R; Garcia Miralles T; Calas A
    Eur Urol; 2005 Sep; 48(3):432-7. PubMed ID: 15963630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cytometry].
    Seigneurin D
    Ann Pathol; 2000; 20 Suppl():S86-7. PubMed ID: 11261308
    [No Abstract]   [Full Text] [Related]  

  • 56. Early diagnosis of bladder cancer.
    Br Med J; 1967 Feb; 1(5535):253-4. PubMed ID: 6017470
    [No Abstract]   [Full Text] [Related]  

  • 57. Bladder cancer: Cancer cell sampling and storage-new filtration device aids collection from urine.
    Stone L
    Nat Rev Urol; 2015 Aug; 12(8):420. PubMed ID: 26195445
    [No Abstract]   [Full Text] [Related]  

  • 58. [Value of impulse cytophotometry for the diagnosis and prognosis of bladder cancer].
    Blech M; Zimmermann A; Truss F
    Helv Chir Acta; 1982 Aug; 49(3-4):415-8. PubMed ID: 7129911
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved application of impulse cytophotometry for the diagnosis of urinary bladder carcinoma.
    Schwabe HW; Adolphs HD
    Urol Res; 1982; 10(2):61-6. PubMed ID: 6180538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.